RxDoctor Payments Data

Sandra Ettema

Otolaryngology · Mattoon, ILNPI 1760577902

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.6%), food and beverage and education — rather than concentrated in one kind of arrangement. Acclarent, Inc accounts for 62.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $1,715 and has fallen 89.3% since, to $184 in 2025.

$2,303in general payments, 2019–2025

Across 29 payments — averaging $79.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$1K
  • Aerin Medical Inc.$353
  • Smith+Nephew$122
  • Phathom Pharmaceuticals, Inc.$110
  • Tactile Systems Technology Inc$86
  • Regeneron Healthcare Solutions, Inc.$75
  • plus $109 from 3 others
$29,503in research payments, 2019–2025

Across 4 payments — averaging $7375.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Tactile Systems Technology Inc$30K

What the payments were for

  • Travel & lodging$1,21153%
  • Food & beverage$1,03345%
  • Education$562%
  • Gifts$40%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,303 in reported general payments places this provider in the 65th percentile of 390 otolaryngology providers in Illinois.

See all otolaryngology providers in Illinois

Medicare billing

Part B allowed, 2024
$66,576
Medicare patients
162
Services billed
628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine326$5,209
Glycopyrrolate40$1,989
Omeprazole78$989
Ipratropium Bromide35$860
Pantoprazole Sodium64$831
Esomeprazole Magnesium17$580
Fluconazole14$483
Propranolol Hcl27$316
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$194
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$130
Tramadol Hcl23$48

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Mattoon

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →